Luisa Albano

1.8k total citations · 1 hit paper
22 papers, 1.1k citations indexed

About

Luisa Albano is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Luisa Albano has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Oncology and 9 papers in Genetics. Recurrent topics in Luisa Albano's work include Virus-based gene therapy research (9 papers), CRISPR and Genetic Engineering (9 papers) and Renal Transplantation Outcomes and Treatments (5 papers). Luisa Albano is often cited by papers focused on Virus-based gene therapy research (9 papers), CRISPR and Genetic Engineering (9 papers) and Renal Transplantation Outcomes and Treatments (5 papers). Luisa Albano collaborates with scholars based in Italy, France and United States. Luisa Albano's co-authors include Samuele Ferrari, Luigi Naldini, Patrizia Gasparini, Aurélien Jacob, Stefano Beretta, Pietro Genovese, Ivan Merelli, Elda Tagliabue, Alessandra Magnifico and Chiara Brombin and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Blood.

In The Last Decade

Luisa Albano

21 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genotoxic effects of base and prime editing in human hematopoietic stem cells

2023 93 citations Samuele Ferrari, Attya Omer et al. Nature Biotechnology profile →

Peers

Countries citing papers authored by Luisa Albano

Since Specialization

Citations

This map shows the geographic impact of Luisa Albano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luisa Albano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luisa Albano more than expected).

Fields of papers citing papers by Luisa Albano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luisa Albano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luisa Albano. The network helps show where Luisa Albano may publish in the future.

Co-authorship network of co-authors of Luisa Albano

This figure shows the co-authorship network connecting the top 25 collaborators of Luisa Albano. A scholar is included among the top collaborators of Luisa Albano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luisa Albano. Luisa Albano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pneumocystis murina lesions in lungs of experimentally infected Cd40l^–/– mice 2024 ·Veterinary Pathology ·(unknown), (unknown), (unknown), Valentina Capo, (unknown), Luisa Albano, Anna Villa, Eugenio Scanziani, Camilla Recordati	0
2	Scalable GMP-compliant gene correction of CD4+ T cells with IDLV template functionally validated in vitro and in vivo 2023 ·Molecular Therapy — Methods & Clinical Development ·Claudia Asperti, Daniele Canarutto, Simona Porcellini, Francesca Sanvito, Francesca Cecere, Valentina Vavassori, Samuele Ferrari, (unknown), Luisa Albano, Aurélien Jacob, Lucia Sergi Sergi, Elisa Montaldo, Francesca Ferrua, Luis Ignacio González‐Granado, Vassilios Lougaris, Raffaele Badolato, Andrea Finocchi, Anna Villa, Marina Radrizzani, Luigi Naldini	3
3	Genotoxic effects of base and prime editing in human hematopoietic stem cells breakdown → 2023 ·Nature Biotechnology ·(unknown), Samuele Ferrari, Attya Omer, Stefano Beretta, Luisa Albano, Daniele Canarutto, Angelica Varesi, (unknown), Chiara Brombin, Federica Cugnata, Erika Zonari, Matteo Maria Naldini, Matteo Barcella, Bernhard Gentner, Ivan Merelli, Luigi Naldini	93
4	Lipid nanoparticles allow efficient and harmless ex vivo gene editing of human hematopoietic cells 2023 ·Blood ·Valentina Vavassori, Samuele Ferrari, Stefano Beretta, Claudia Asperti, Luisa Albano, Andrea Annoni, (unknown), Angelica Varesi, Monica Soldi, Alessandro Cuomo, Tiziana Bonaldi, Marina Radrizzani, Ivan Merelli, Luigi Naldini	40
5	P1373: UNCOVERING UPSIDES AND PITFALLS OF BASE AND PRIME EDITING IN HEMATOPOIETIC STEM CELLS 2023 ·HemaSphere ·(unknown), Samuele Ferrari, Attya Omer, Stefano Beretta, Luisa Albano, Daniele Canarutto, Angelica Varesi, (unknown), Chiara Brombin, Federica Cugnata, Erika Zonari, Matteo Maria Naldini, Matteo Barcella, Bernhard Gentner, Ivan Merelli, Luigi Naldini	1
6	Mobilization-based chemotherapy-free engraftment of gene-edited human hematopoietic stem cells 2022 ·Cell ·Attya Omer, (unknown), Luisa Albano, (unknown), Claire Latroche, (unknown), Samuele Ferrari, (unknown), Aurélien Jacob, Valentina Vavassori, Alessandro Nonis, Daniele Canarutto, Luigi Naldini	36
7	BAR-Seq clonal tracking of gene-edited cells 2021 ·Nature Protocols ·Samuele Ferrari, Stefano Beretta, Aurélien Jacob, Davide Cittaro, Luisa Albano, Ivan Merelli, Luigi Naldini, Pietro Genovese	9
8	Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking 2020 ·Nature Biotechnology ·Samuele Ferrari, Aurélien Jacob, Stefano Beretta, Giulia Unali, Luisa Albano, Valentina Vavassori, Davide Cittaro, Dejan Lazarević, Chiara Brombin, Federica Cugnata, Anna Kajaste‐Rudnitski, Ivan Merelli, Pietro Genovese, Luigi Naldini	108
9	Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response 2019 ·Cell stem cell ·Giulia Schiroli, Anastasia Conti, Samuele Ferrari, Lucrezia della Volpe, Aurélien Jacob, Luisa Albano, Stefano Beretta, Andrea Calabria, Valentina Vavassori, Patrizia Gasparini, Eralda Salataj, Delphine Ndiaye‐Lobry, Chiara Brombin, Julie Chaumeil, Eugenio Montini, Ivan Merelli, Pietro Genovese, Luigi Naldini, Raffaella Di Micco	203
10	PRODIG (Prevention of new onset diabetes after transplantation by a short term treatment of Vildagliptin in the early renal post-transplant period) study: study protocol for a randomized controlled study 2019 ·Trials ·Émilie Gaiffe, Thomas Crépin, Jamal Bamoulid, Cécile Courivaud, M. Büchler, Élisabeth Cassuto, Luisa Albano, Jonathan Chemouny, Gabriel Choukroun, Marc Hazzan, Laurence Kessler, (unknown), Yannick Le Meur, Nacéra Ouali, Antoine Thierry, Amélie Anota, Virginie Nerich, Samuel Limat, Franck Bonnetain, Déwi Vernerey, (unknown)	6
11	Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1 2017 ·Science Translational Medicine ·Giulia Schiroli, Samuele Ferrari, Anthony Conway, Aurélien Jacob, Valentina Capo, Luisa Albano, Tiziana Plati, Maria Carmina Castiello, Francesca Sanvito, Andrew R. Gennery, Chiara Bovolenta, Rahul Palchaudhuri, David T. Scadden, Michael C. Holmes, Anna Villa, Giovanni Sitia, Angelo Lombardo, Pietro Genovese, Luigi Naldini	159
12	Efficacy of Prolonged- and Immediate-release Tacrolimus in Kidney Transplantation: A Pooled Analysis of Two Large, Randomized, Controlled Trials 2017 ·Transplantation Proceedings ·Bernhard K. Krämer, Luisa Albano, Bernhard Banas, B Charpentier, Lars Bäckman, Hélio Tedesco‐Silva, Frank Lehner, (unknown), Maciej Głyda, E. Cassuto‐Viguier, Ondřej Viklický, G. Mourad, Paolo Rigotti, (unknown), Nassim Kamar	10
13	42. Correction of SCID-X1 by Targeted Genome Editing of Hematopoietic Stem/Progenitor Cells (HSPC) in the Mouse Model 2016 ·Molecular Therapy ·Giulia Schiroli, Pietro Genovese, Valentina Capo, Maria Carmina Castiello, Luisa Albano, Michael C. Holmes, Anna Villa, Giovanni Sitia, Angelo Lombardo, Luigi Naldini	1
14	Targeting Peptidyl-Prolyl Isomerase Pin1 to Inhibit Tumor Cell Aggressiveness 2016 ·Tumori Journal ·Giovanni Luca Beretta, Michelandrea De Cesare, Luisa Albano, Alessandra Magnifico, Nives Carenini, Elisabetta Corna, Paola Perego, Laura Gatti	4
15	Everold: A Multicenter Randomized Study for the Use of Everolimus in “Old-for-Old” Renal Transplantation. 2014 ·Transplantation ·Yannick Le Meur, Markus W. Büchler, (unknown), Marie‐Christine Moal, Luisa Albano, Pierre Merville, Sophie Caillard, Isabelle Étienne, Marc Hazzan, Dany Anglicheau, Jean Philippe Rerolle, (unknown), Antoine Thierry, (unknown), Olivier Toupance, Valérie Châtelet, Hakim Mazouz, G. Mourad, Nassim Kamar	5
16	EGFR through STAT3 modulates ΔN63α expression to sustain tumor‐initiating cell proliferation in squamous cell carcinomas 2012 ·Journal of Cellular Physiology ·(unknown), Luisa Albano, Anna Rossini, (unknown), Sonia Fabris, Roberto Mantovani, Antonino Neri, Andrea Balsari, Alessandra Magnifico, Elda Tagliabue	22
17	Histological Progression of Interstitial Fibrosis/Tubular Atrophy (IF/TA) According to Epithelial-Mesenchymal Transition (EMT) Profile: The CERTITEM Trial 2012 ·Transplantation ·Lionel Rostaing, Alexandre Hertig, Luisa Albano, Dany Anglicheau, Antoine Dürrbach, Olivier Toupance, Bruno Moulin, Pierre Merville, Marc Hazzan, (unknown), Guy Touchard, Bruno Hurault de Ligny, Stéphane Quéré, F. Di Giambattista, (unknown), Eric Rondeau	3
18	Molecular cytogenetic characterization of stem-like cancer cells isolated from established cell lines 2010 ·Cancer Letters ·Patrizia Gasparini, Giulia Bertolini, Mara Binda, Alessandra Magnifico, Luisa Albano, Monica Tortoreto, Graziella Pratesi, Federica Facchinetti, (unknown), Luca Roz, Elda Tagliabue, Maria Grazia Daidone, Gabriella Sozzi	9
19	Tumor-Initiating Cells of HER2-Positive Carcinoma Cell Lines Express the Highest Oncoprotein Levels and Are Sensitive to Trastuzumab 2009 ·Clinical Cancer Research ·Alessandra Magnifico, Luisa Albano, Stefano Campaner, Domenico Delia, Fabio Castiglioni, Patrizia Gasparini, Gabriella Sozzi, Enrico Fontanella, Sylvie Ménard, Elda Tagliabue	202
20	Protein Kinase Cα Determines HER2 Fate in Breast Carcinoma Cells with HER2 Protein Overexpression without Gene Amplification 2007 ·Cancer Research ·Alessandra Magnifico, Luisa Albano, Stefano Campaner, Manuela Campiglio, Silvana Pilotti, Sylvie Ménard, Elda Tagliabue	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact